Application
Mouse Nlk Antibody (C-term) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the Nlk antibody detected the Nlk protein (arrow).Application
Mouse Nlk Antibody (C-term) western blot analysis in mouse lung tissue lysates (35ug/lane).This demonstrates the Nlk antibody detected the Nlk protein (arrow).Application
Mouse Nlk Antibody (C-term) (AP13929b)immunohistochemistry analysis in formalin fixed and paraffin embedded mouse brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of Mouse Nlk Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | Nlk Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | Nlk; Serine/threonine-protein kinase NLK; Nemo-like kinase |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | Nlk Serine/threonine-protein kinase NLK Nemo-like kinase |
|---|---|
| Molecular Weight(MW) | 58313 Da |
| Function | Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK- SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1 Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1 |
| Tissue Specificity | Expressed at high levels in the brain, and at lower levels in heart, kidney, lung and liver |
| Cellular Localization | Nucleus. Cytoplasm. Note=Predominantly nuclear. A smaller fraction is cytoplasmic |
| Entrez Gene | 18099 |
|---|---|
| Nucleotide Accession | NP_032728.3 XP_001472539.1 |
Application
Mouse Nlk Antibody (C-term) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the Nlk antibody detected the Nlk protein (arrow).
Application
Mouse Nlk Antibody (C-term) western blot analysis in mouse lung tissue lysates (35ug/lane).This demonstrates the Nlk antibody detected the Nlk protein (arrow).
Application
Mouse Nlk Antibody (C-term) (AP13929b)immunohistochemistry analysis in formalin fixed and paraffin embedded mouse brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of Mouse Nlk Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
